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p70S6KLipid composition and fatty acid analysis of the major classes of membrane phospholipids were determined
during myogenic differentiation of L6 skeletal muscle cells. The cholesterol to glycerophospholipids ratio
decreased during differentiation, both in total (TM) and detergent-resistant membranes (DRM). Analyses
of the membrane lipids showed that differentiation had a major impact on the molecular composition of
glycerophospholipids. A signiﬁcant decrease in the concentration of saturated fatty acids was detected in
glycerophospholipid classes, and to a lesser extent in sphingolipids, while the concentration of 16:1n-7,
18:1n-7 and 18:1n-9 increased. At the same time, the concentration of long polyunsaturated fatty acid chains
decreased in TM and DRM glycerophospholipids, resulting in a lower saturated to unsaturated fatty acid ratio
in myotubes as compared to myoblasts. Interestingly, the observed n-3/n-6 ratio was lower in differentiated
cell membranes. PUFA supplementation of L6 cells led to an increase in myogenic differentiation correlated to
an incorporation of added PUFAs in TM and DRM glycerophospholipids. As expected after n-3 PUFA supple-
mentation, the n-3/n-6 ratio was clearly increased in TM and, surprisingly, this was also the case in isolated
DRM. n-3 and n-6 PUFAs signiﬁcantly and time-dependently increased the phosphorylation of kinase
p70S6K1 during myogenic differentiation, revealing the activation of the upstream kinase mTORC1, a
major regulator of cell cycle and protein translation. In contrast, PUFAs did not affect the phosphorylation
of the kinase Akt, another pivotal regulator of cell metabolism. These results suggest that PUFA supplemen-
tation modiﬁed the membrane lipid composition and affected the differentiation of L6 cells.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Skeletal muscle formation or myogenesis is a complex and highly
regulated process that results in the conversion of proliferating
skeletal myoblasts into polynucleated myotubes expressing the
contractile apparatus [1]. Differentiation of proliferating myoblasts
begins with the sequential expression of myogenic regulatory factors,
followed by the exit of these myoblasts from the cell cycle, the
expression of the proteins of the contractile apparatus, and ﬁnally
the formation of multinucleated myotubes by cell fusion [1–3].
Skeletal myogenesis is mediated by a network of signal transduction
pathways that regulates withdrawal from the cell cycle and speciﬁc
myogenesis. In recent years, several signalling pathways have emerged
as important regulators of muscle formation and maintenance. Among
them, the p38 mitogen-activated protein kinase (p38 MAPK) and the
phosphoinositide-3-kinase (PI3K)/Akt pathways are thought to have
key roles in the control of muscle gene expression and muscle protein
synthesis during myogenic differentiation [4–6].: +33 4 72 43 15 57.
. Bessueille).
l rights reserved.Besides these intracellular mechanisms governing cell differentia-
tion, cell surface properties (determined by membrane composition)
are also of primary importance. Lipids are responsible for the physico-
chemical properties of the membrane itself, largely determining its
asymmetry, ﬂuidity and plasticity, and its organization in domains.
Over the past few years, the simple model of biological membranes
has been modiﬁed to recognize that one of their most important
features is their ability to locally form specialized domains with a
different composition and physical properties from the rest of the
plasmamembrane [7,8]. Lipid rafts or detergent-resistant membranes
(DRM) are dynamic structures within the cell membrane, which
are enriched in both sphingolipids with highly saturated acyl chains
and cholesterol [9]. It is well accepted that lipids from the cellular
membrane can be remodeled by altering dietary fat intake, especially
by modulating the content of n-3 or n-6 polyunsaturated fatty
acids (PUFAs) [10–12]. The incorporation of these PUFAs in mem-
brane lipids considerably affects the physical properties of the
membrane, including ﬂuidity, phase transition temperature and
lipid-protein interactions [13,14]. The level of unsaturation and the
length of the phospholipid fatty acyl chains, as well as the cholesterol
to phospholipid ratio have been found to inﬂuence a number of
important functions in skeletal muscle. For example, the ﬂuidity of
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and as its unsaturated fatty acid content rises [15]. Decreased insu-
lin sensitivity of muscle tissue has been associated with decreased
concentrations of polyunsaturated fatty acids in phospholipids,
raising the possibility that changes in the fatty-acid composition
of membranes modulate the action of insulin [16]. Several studies
have demonstrated the modulatory role of long-chain PUFAs
within the lipid microenvironment of certain enzymes [17–19].
Furthermore, it was recently observed that fatty acids modulate
the proliferation and differentiation of C2C12 or L6 skeletal muscle
cells [20,21]. Since PUFAs are incorporated in cell membrane
lipids, some of their biological effects could be due to their effects
on membrane composition and function [10,22]. However, no
systematic studies of their incorporation in total cell membranes
and in the detergent-resistant membranes have been carried
out in both myoblasts and myotubes, in relation with myogenic
differentiation.
In the present study, we have analyzed the lipid composition
of total membranes (TM) and DRM isolated from L6 myoblasts and
myotubes. We observed that not only the TM, but also the isolated
DRM of L6 cells undergo a modiﬁcation of their lipid composition
during differentiation. We then used fatty acid-supplemented culture
media to modulate membrane lipid-composition and to investigate
the effects associated with fatty acid changes during differentiation.
In an effort to elucidate the molecular mechanisms through which
fatty acids inﬂuence myogenesis, we ﬁnally evaluated the status
of the Akt/mTORC1/S6K1 signalling pathway in differentiating
L6 cells submitted to fatty acid supplementation. This pathway
is a central regulator of cell metabolism, growth, proliferation and
differentiation.
2. Materials and methods
2.1. Materials
Dulbecco's modiﬁed essential medium (DMEM), fetal bovine
serum (FBS), and antibiotic solution were from Life Technologies.
All other reagent-grade chemicals (AVP, BSA, PUFAs, horseradish
peroxidase-conjugated anti-mouse IgG) were obtained from Sigma-
Aldrich. Antibodies against myogenin (F5D clone) and myosin (MF20
clone) were obtained from the Developmental Studies Hybridoma
Bank (DSHB) developed under the auspices of the NICHD and
maintained by the University of Iowa, Department of Biology, Iowa
City, IA 52242. Anti-caveolin, anti-phospho-p70S6K and anti-Akt were
from BD Biosciences, Alexaﬂuor 488 goat anti-mouse IgG was from
Invitrogen. Creatine kinase assay kit was purchased from Sobioda,
cholesterol assay kit from Molecular probes and phospholipid assay
kit from Biolabo.
2.2. Cell culture
Cells of the subclone C5 (L6-C5), a clone that had shown a signif-
icant capacity for differentiation [23], were used throughout this
study. L6C5 rat skeletal myoblasts (obtained from Dr. F. Naro, Univer-
sity of Roma, Italy) were maintained in Dulbecco's modiﬁed Eagle's
medium (DMEM) containing 4.5 g/L glucose and supplemented
with 10% (v/v) fetal bovine serum (FBS), 2 mM glutamine, 20 mM
HEPES, 100U/ml penicillin and 100 μg/ml streptomycin (growth
medium, GM) at 37 °C in a 5% CO2 humidiﬁed atmosphere. Cells
were subcultured every 2–3 days. For differentiation, cells were
seeded at the density of 3000/cm2. 72 h after plating, cultures were
washed twice with Dulbecco's-PBS (D-PBS) and differenciation
was induced by reducing the serum level to 1% and adding 0.1 μM
Arg8-vasopressin (differentiation medium, DM). In these conditions,
L6C5 myoblasts differentiate in 2–4 days.2.3. Fatty acid treatment
The effects of different fatty acids on myogenic differentiation
of L6 cells were determined by allowing the cells to differentiate
in differentiation media supplemented with either fatty-acid free
BSA (150 μM) or one of the following albumin-bound fatty acids
(20 μM): oleic acid (OA; 18:1 n-9), arachidonic acid (AA; 20:4 n-6),
eicosapentaenoic acid (EPA; 20:5 n-3) or docosahexaenoic acid
(DHA; 22:6 n-3).
The molar ratio of fatty acids to albumin was 1:7.5.
2.4. Immunoﬂuorescence staining
Cells cultured in 12-well dishes were washed with D-PBS,
followed by ﬁxation for 10 min with 3.7% paraformaldehyde and
subsequently permeabilized in D-PBS containing 0.1% Triton X-100
for 10 min at room temperature. After three one-minute washes
with D-PBS, the cells were blocked with 1% bovine serum albumin
in D-PBS for 30 min and then incubated for 1 h with monoclonal
myogenin or anti-myosin primary antibodies diluted with D-PBS
to 1:1000. After four additional washes with D-PBS, the cells were
incubated for 1 h at room temperature in the dark with Alexa-
ﬂuor-coupled secondary antibodies diluted in a blocking solution to
1:1000. Finally, the cells were washed three times in D-PBS. Fluores-
cent images were captured by an Axiovert-Zeiss inverted microscope
(Zeiss, France). As a morphological parameter of muscle differentia-
tion, themyogenic index was deﬁned as the number of nuclei residing
in the cell containing three or more nuclei divided by total number of
nuclei in stained cells. The distribution of nuclei in myoblasts and
myotubes wasmeasured by counting the nuclei in at least 10 different
locations selected randomly.
2.5. Creatine kinase assay
The activity of creatine kinase (CK)wasmeasured to biochemically
assess myogenic differentiation. After appropriate treatments and at
the end of the incubation period, the cells were collected and
centrifuged for 10 min at 500 ×g. The pellet was resuspended in
20 mMTris–HCl pH 6.7, 1 mMEDTA. After sonication the homogenate
was either used immediately for CK assays or stored at −80 °C for
future use. The protein content in the samples was measured using
the Bio-Rad protein assay reagent. CK activity was measured using a
spectrophotometric-based kit (Sobioda). Speciﬁc activity of CK was
calculated after correction for total protein content and deﬁned as
μmol/min per milligram of protein (μmol/min/mg).
2.6. Preparation of membrane fraction and isolation of DRM
The cells were homogenized in ice-cold Tris–HCl 25 mM pH 7.5,
150 mM NaCl, 5 mM EDTA containing a protease-inhibitor cocktail
(TNE) and disrupted in a Potter homogenizer (40 strokes). The
homogenate was subjected to centrifugation (900 ×g, 10 min) at
4 °C to remove unbroken cells and nuclei, and the supernatant was
saved. This post-nuclear supernatant was centrifuged for 45 min at
100,000 ×g to obtain the total membrane (TM) fraction (plasma
membrane and cytoplasmic vesicular structures). To maintain a
constant detergent-to-protein ratio in all the experiments, the pellet
was resuspended in TNE buffer and submitted to a protein assay.
The TM fraction was incubated with 1% Triton X-100 at 4 °C for
30 min (ﬁnal protein-to-detergent ratio: 3). In all cases, the samples
were then mixed with an equal volume of 89% sucrose in Tris–HCl
25 mM pH 7.5, 150 mM NaCl, placed at the bottom of linear 5–40%
sucrose density gradients and fractionated by ﬂotation (centrifuga-
tion at 150,000 ×g for 20 h at 4 °C). 1 ml fractions were collected
from the bottom of the ultracentrifuge tubes and submitted to further
analysis.
604 A. Briolay et al. / Biochimica et Biophysica Acta 1828 (2013) 602–6132.7. Lipid analyses
Total lipids were extracted from membrane or microdomain sam-
ples according to a modiﬁcation of the method of Bligh and Dyer [24].
One ml of each sample was mixed with 3.75 ml methanol/chloroform
(2/1, v/v), vigorously shaken for 1 min, incubated at room tempera-
ture for 30 min and centrifuged for 10 min at 2000 ×g. The pellet
contained precipitated proteins which were discarded. Chloroform
(1.25 ml) and water (1.25 ml) were subsequently added to the
supernatant and phase separation was performed by centrifugation
at 2000 ×g for 10 min. The lower organic phase containing the
extracted lipids was collected and dried under a stream of N2. Total
lipids were re-dissolved in chloroform and either analyzed by thin
layer chromatography (TLC) or used for various assays. Total phos-
pholipids were assayed by the ammonium ferrothiocyanate method
[25] and by using the Enzymatic Colorimetric kit from Wako
Chemicals (Germany). The enzymatic Amplex Red Cholesterol Assay
kit from Molecular probes was used to quantify cholesterol.
Major lipid classes were separated by TLC in one dimension on 60
silica-gel plates (Merck, 25×25 cm), using two-solvent systems.
Lipids were quantitatively applied to TLC plates and development
was carried out in ethyl acetate–propanol–chloroform–methanol–
0.25% aqueous KCl (25:25:25:10:9, by vol.). After the solvent had
reached 10 cm from the bottom of the plates, the latter were
dried thoroughly and developed in hexane–diethyl ether–acetic acid
(75:21:4, v/v/v) for an additional 6 cm migration. The plates were
then dried and lipids were stained by dipping the TLC plates into a
mixture of 10% cupric sulphate (w/v) and 8% phosphoric acid (v/v).
After 10 min at 180 °C the plates were scanned from the point of ori-
gin to the solvent front by using a Camag II TLC scanning densitometer.
Quantiﬁcation was carried out by in situ densitometry with absolute
amounts of the lipid classes determined from co-chromatographed
standards [26] using the CATS software analysis package from
Camag. Lipid standards (0.5 to 10 ng) were prepared by dissolving
commercially available lipids (phosphatidic acid, PA; phosphatidyl-
choline, PC; phosphatidylethanolamine, PE; phosphatidylglycerol,
PG; phosphatidylinositol, PI; phosphatidylserine, PS; cholesterol, CH;
and sphingomyelin, SM from Sigma) in chloroform.
2.8. Fatty acid analysis by GC
Total lipids were separated by 2D high-performance TLC
(2D-HPTLC) using a CAMAG horizontal developing chamber. The
developing solvent used for the ﬁrst dimension was chloroform–
methanol–NH4OH (65:25:5), whereas the second dimension was
developed in chloroform–acetone–methanol–acetic acid–water
(30:40:10:10:5). Lipids were then stained by spraying the plate
with a solution of 0.02% (w/v) dichloroﬂuorescein in 95% ethanol. The
spots corresponding to the poorly resolved glycerophospholipids
phosphatidylserine (PS) and phosphatidylinositol (PI) or sphingolipids
(SL) on one hand, and the spots corresponding to phosphatidylcholine
(PC) or phosphatidylethanolamine (PE) on the other hand were
scraped and transesteriﬁed at 100 °C for 90 min in 250 μl of toluene-
methanol (40:60) and 250 μl of BF3 10% in methanol. The reaction
was stopped in ice by adding 1.5 ml of 10% K2CO3 (w/v), and fatty
acid methyl esters were extracted with 2 ml of isooctane. The deriva-
tives were analyzed by gas chromatography (GC) using an Agilent
Technologies chromatograph (model 6890) ﬁtted with a SolGel 1 ms
dimethylpolysiloxane capillary column (60 mm by 0.2 mm [inner
diameter], 0.25-μm ﬁlm thickness; SGE Europe, Ltd., France). The oven
temperature was set at 80 °C for 1.5 min and increased to 150 °C at
20 °C min−1 and then to 250 °C at 2 °C min−1. The temperature was
maintained at 250 °C for 10 min before returning to the initial condi-
tions. Helium was used as the carrier gas at 1 ml min−1. The tempera-
tures of the split/splitless injector and the ﬂame ionization detector
were set at 230 and 280 °C respectively.2.9. SDS/PAGE and immunoblotting
Cell lysates and membrane fractions from L6 myoblasts or
myotubes (20 μg protein) were separated by SDS-PAGE, transferred
onto Hybond-C membranes (Amersham Pharmacia Biotech), and
subjected to Western blot analysis with different antibodies. Brieﬂy,
for the analysis of myosin and caveolin-3, the ﬁrst antibody incuba-
tion (overnight at 4 °C) was carried out with a 1:2000 dilution of
the mouse monoclonal antibodies (MF20 and clone 26 respectively).
Second antibody incubation was carried out with a 1:2000 dilution
of anti-mouse immunoglobulin G antibody conjugated to HRP
(Sigma). Immunostained bands were detected by the ECL method
(GE Healthcare). The same Hybond-C membrane was stripped to
detach the anti-caveolin or anti-myosin antibody and was subjected
to western blotting using a monoclonal anti-α-tubulin antibody.
2.10. Statistical analysis
Data are presented as mean±standard error (SE). For statistical
comparison, the t-test was employed using XLSTAT software. p-values
under 0.05 were considered to be statistically signiﬁcant.
3. Results
3.1. Effects of the differentiation on lipid and fatty acid composition of
total membranes and DRM
Modulation of membrane lipid composition is known to have an
effect on various cell signalling pathways. In order to investigate the
relationship between lipid composition and myogenic differentiation,
we ﬁrst isolated TM and DRM from undifferentiated and differentiated
L6 cells, and we assessed their lipid and fatty acid compositions. To
allow comparison of the results obtainedwith different cell populations,
TM were extracted with cold Triton X-100 at a constant detergent to
membrane-protein ratio. The resulting detergent-resistant prepara-
tions were fractionated using sucrose-density-gradient sedimentation.
The Triton X-100 sucrose-density fractions were analyzed for total
protein and cholesterol content, and speciﬁc raft markers (Fig. 1). The
distribution of total proteins showed that most of the membrane pro-
teins were detergent soluble as they appeared solubilized in the high
density fractions. In contrast, the sucrose-density-gradient fractions
showed a narrow distribution of the activity of alkaline phosphatase, a
glycosylphosphatidylinositol-anchored enzyme considered a reliable
marker of DRM, with the entire activity recovered in the low-density
fractions (centred around 20% sucrose), as insoluble material. Caveolin
is another raft-associated protein located at the cytosolic face of the
membrane, and anchored by acylation and membrane-spanning seg-
ments. Western blot analysis performed on sucrose-density fractions
showed that the bulk of caveolin-1 was recovered in the DRM fractions
of both myoblasts and myotubes. Concerning caveolin-3, as expected, a
strong increase of its expression was observed in differentiated cells
compared to undifferentiated cells. Caveolin-3 was detected in the
low-density fractions corresponding to the DRM of differentiated
L6 myotubes. It should be noted that the puriﬁcation of DRM was not
impaired by the different levels of caveolin-3 expression between
myotubes and myoblasts. A bimodal cholesterol proﬁle was observed
in both cases, with one peak corresponding to the low-density frac-
tions, and the remainder found in the high-density fractions at the
bottom of the gradient. Furthermore, the location of DRM-containing
fractions was conﬁrmed by dot-blot analysis of the reliable lipid raft
marker ganglioside GM1. GM1 was highly enriched in a single peak,
in both myoblasts and myotubes, indicating that virtually all of
this glycosphingolipid was associated to the low-density fractions. In
contrast the transferrin receptor, a negative marker for DRM, was
excluded from the low-density fractions and localized at the bottom
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Fig. 1. Puriﬁcation of DRMs. The total membranes of L6 myoblasts (A) or myotubes (B)
were extracted with 1%Triton X-100 and fractionated by sucrose-density-gradient
centrifugation. The distribution of phospholipids and cholesterol was determined in
the gradient fractions collected from the bottom of the tube (Fraction 1: bottom of
the gradient: 40% sucrose; fraction 15: top of the gradient: 5% sucrose). Phospholipid
and cholesterol contents are expressed as μg/ml of fraction. The distribution of alkaline
phosphatase, a GPI-linked DRM-associated protein, was examined by assaying the
activity expressed in U mL−1. Gradient fractions were analyzed by Dot-blotting or
Western immunoblotting followed by ECL® detection for the lipid-raft markers GM1
and caveolins 1 and 3.
Table 1
Relative proportions of different classes of lipids in the total membrane and DRM frac-
tions (expressed as the molar ratio of the total lipid content analyzed for each sample).
Myoblasts Myotubes
TM DRM TM DRM
Saturated/
unsaturated
0.82±0.20 1.28±0.16# 0.66±0.00* 1.16±0.22#
n-3/n-6 0.621±0.19 0.575±0.15 0.322±0.07* 0.316±0.05
Cholesterol/GPL 0.326±0.091 1.345±0.162# 0.167±0.064* 1.105±0.050#
Sphingomyelin/
GPL
0.123±0.032 0.347±0.073 0.125±0.013 0.384±0.047
These data represent the means from 3 separate experiments±SE.
*pb0.05 myotubes vs. myoblasts #pb0.05 DRM vs. TM.
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solubilized by Triton X-100 was found (data not shown).
We then combined TLC, GC and enzymatic assays to compare
the lipid composition of TM and DRM (Tables 1 and 2). In spite of a
similar general proﬁle, TM and DRM exhibited clear differences in
terms of relative abundance of the different classes of lipids. Brieﬂy,glycerophospholipids (GPL) in TM of myoblasts represented more
than 50% of total lipids with major phospholipids being PC and
PE. As expected, the DRM presented a much higher cholesterol to
glycerophospholipid (CH/GPL) ratio. The differentiation of L6 cells
was associated with changes of lipid class proportions. As shown in
Table 1, differentiation induced a marked decrease in the CH/GPL
in TM, from 0.326 in myoblasts to 0.167 in myotubes. The CH/GPL
ratio was correlated with the ratio of saturated to unsaturated fatty
acids (0.82 and 0.66 for myoblasts and myotubes respectively), as
well aswith the ratio of n-3 to n-6 fatty acids (0.621 and 0.322 for myo-
blasts and myotubes respectively). By contrast, the sphingomyelin to
glycerophospholipid ratio observed in TM remained constant during
the differentiation process.
Membrane sphingolipid and glycerophospholipid fatty acid com-
positions of L6 cells are shown in Table 2. When the relative molar
composition (mol %) was considered, it was apparent that the pre-
dominant fatty acids in myoblast membranes were saturated (16:0,
18:0) and monounsaturated (18:1 n-9 and 18:1 n-7). PC mainly
comprised saturated 16:0, while PE contained more 18:0. The higher
contents of 16:0 in PC and of 18:0 in PE are consistent with the
known predilection of these fatty acids in the sn-1 position of the
corresponding glycerophospholipids. By comparison, SL contained
much more 16:0 fatty acids, whereas the amount of 18:0 was similar.
Myoblast membrane lipids contained 46% of saturated fatty acids on
average, and the highest saturated/unsaturated ratio was observed
in the sphingolipid fraction, followed by PI/PS, PC and ﬁnally PE.
Furthermore, our results showed that glycerophospholipids were
enriched in long-chain n-3 and n-6 series, as compared to sphingolipids.
On the other hand, the presence of very long chain fatty acids, such as
24:0 and 24:1 n-9, was only observed in the SL fraction.
The greatest difference in myotube fatty acid content, as compared
with myoblasts, was observed in the saturated fatty acids of all mem-
brane lipids. Myotubes had a signiﬁcantly reduced content of 16:0
and 18:0, with a concomitant increase in the monounsaturated fatty
acids 16:1 n-7, 18:1 n-9 and 18:1 n-7. Thus, the ratio of saturated to
unsaturated fatty acids was signiﬁcantly lower in myotube mem-
branes compared to those of myoblasts. On the other hand, the
content in long chain polyunsaturated fatty acid (20:4 n-6; 20:5
n-3; 22:5 n-3 and 22:6 n-3) decreased during L6 differentiation.
Differentiation was also accompanied by changes in the relative
distribution of n-3 and n-6 polyunsaturated fatty acids. We observed
that the ratio of n-3 to n-6 fatty acids in myotube membranes was
signiﬁcantly lower than in myoblast membranes (Table 1). In parallel,
the total amounts of n-7 and n-9 fatty acids increased, with 18:1 n-7
being the most affected (Table 2).
We then determined whether DRM isolated from differentiated
L6 myotubes showed differences in the relative proportion of phos-
pholipid and in phospholipid-fatty acyl composition, as compared
to the DRM from undifferentiated myoblasts. As mentioned above
(Table 1) the CH/GPL ratio in TM was signiﬁcantly higher in myo-
blasts than in myotubes. After extraction with 1% Triton X-100, the
CH/GPL ratio in the DRM isolated from myoblasts was still higher
Table 2
Fatty acid composition of total membrane and DRM lipids from L6 myoblasts and myotubes.
Myoblasts TM Myotubes TM
Fatty acids SL PC PI/PS PE SL PC PI/PS PE
14:0 0.48±0.07 3.33±1.72 0.17±0.07 0.57±0.09 1.42±0.00 6.60±0.98⁎ 0.90±0.01⁎ 0.53±0.03
16:0 51.84±5.77 32.01±5.32 5.32±0.68 7.85±1.29 57.21±3.34⁎ 25.09±1.47⁎ 5.08±0.05 5.58±0.31⁎
18:0 11.96±2.62 10.88±1.85 45.13±2.84 18.5±3.44 9.67±0.40 7.22±0.34⁎ 35.89±0.77⁎⁎ 10.62±0.16⁎
20:0 2.58±0.05 0.17±0.08 0.4±0.27 0.23±0.22 1.43±0.08⁎⁎⁎ 0.12±0.04 0.30±0.08 0.32±0.09
22:0 4.02±0.87 0.05±0.04 0.36±0.17 0.21±0.20 3.04±0.31 0.03±0.03 0.22±0.09 0.15±0.07
24:0 3.79±1.97 0.04±0.04 0.61±0.25 0.78±0.18 3.55±0.51 0.00±0.00 0.09±0.04 0.02±0.02
16:1 n-9 0.00±0.00 3.33±0.20 0.89±0.01 0.68±0.13 0.61±0.04⁎⁎⁎ 3.98±0.02⁎ 1.72±0.22⁎ 0.64±0.17
16:1 n-7 0.00±0.00 5.58±0.36 1.63±0.35 2.39±0.52 0.22±0.08⁎ 13.58±1.60⁎ 5.85±0.51⁎⁎⁎ 7.02±0.76⁎⁎⁎
18:1 n-9c 2.55±1.07 20.18±4.58 16.7±3.07 17.37±1.43 3.13±1.92 20.33±0.98 21.27±0.81⁎ 22.20±0.54⁎
18:1 n-7 0.34±0.29 11.35±1.38 7.4±0.32 5.63±0.61 1.52±0.52 15.68±0.22⁎ 14.03±1.46⁎ 12.08±0.89⁎⁎
18:2 n-6c 0.61±0.25 2.83±0.88 1.82±0.23 2.06±0.35 0.56±0.24 0.68±0.02⁎ 0.48±0.03⁎⁎ 0.73±0.03⁎
20:2 n-6 0.00±0.00 0.15±0.22 0.23±0.07 0.08±0.04 0.12±0.07 0.21±0.13 0.05±0.03 0.04±0.01
20:3 n-6 0.24±0.14 0.59±0.13 1.54±0.05 0.90±0.13 1.79±0.71 0.18±0.00⁎ 0.61±0.02⁎⁎⁎ 0.45±0.01⁎⁎
20:4 n-6 0.00±0.00 2.72±1.18 7.66±1.92 10.82±1.52 0.50±0.11 0.51±0.14 2.36±0.04⁎ 5.13±0.53⁎⁎⁎
20:5 n-3 0.00±0.00 0.58±0.25 0.44±0.02 2.33±1.01 0.00±0.00 0.04±0.03⁎ 0.06±0.03⁎ 0.67±0.02
22:4 n-6 0.62±0.47 0.09±0.03 0.50±0.21 1.21±1.03 0.00±0.00 0.03±0.02 0.25±0.00 0.78±0.09
22:5 n-3 0.00±0.00 0.69±0.07 2.09±1.03 5.31±0.23 0.00±0.00 0.14±0.01⁎⁎⁎ 0.74±0.03 2.15±0.10⁎⁎⁎
22:6 n-3 0.00±0.00 0.54±0.02 1.3±0.31 4.38±1.33 0.00±0.00 0.16±0.04⁎⁎⁎ 0.50±0.01 1.51±0.13⁎
24:1 n-9 15.5±1.22 0.05±0.05 0.96±0.49 0.05±0.03 12.18±0.68⁎ 0.06±0.03 0.11±0.02 0.00±0.00
Saturated/unsaturated 3.76±0.87 0.96±0.18 1.2±0.17 0.53±0.09 3.70±0.05 0.70±0.03⁎ 0.95±0.04 0.32±0.01⁎
n-3/n-6 0.00±0.00 0.28±0.05 0.33±0.13 0.80±0.18 0.00±0.00 0.21±0.01⁎ 0.35±0.01 0.61±0.05⁎
Myoblasts DRM Myotubes DRM
Fatty acids SL PC PI/PS PE SL PC PI/PS PE
14:0 1.02±0.45 5.14±1.76 1.28±1.01 1.37±1.06 1.00±0.04 7.96±2.98 1.11±0.35 0.95±0.44
16:0 59.92±9.32 42.51±0.51# 9.85±0.34## 11.37±2.92 54.02±6.96 38.02±4.01# 14.73±0.54⁎⁎⁎ ### 10.62±1.12#
18:0 11.77±2.46 9.57±0.49 43.13±2.01# 20.58±1.73 10.86±0.55# 7.86±0.73 38.86±2.71 13.66±0.28⁎ ###
20:0 2.26±0.44 0.00±0.00# 0.17±0.14### 0.08±0.04# 1.59±0.42 0.07±0.06 0.15±0.13 0.16±0.12
22:0 2.83±0.92 0.00±0.00 0.15±0.12## 0.00±0.00 2.85±0.87 0.00±0.00 0.00±0.00# 0.03±0.03
24:0 1.09±0.54 0.00±0.00 0.29±0.24 0.55±0.38 2.86±0.95 0.01±0.02 0.07±0.06 0.01±0.01
16:1 n-9 0.00±0.00 2.50±0.31### 1.18±0.49 0.74±0.16 0.49±0.16⁎ 2.53±0.29## 1.51±0.20 0.68±0.15
16:1 n-7 0.00±0.00 3.49±0.59### 1.35±0.06 1.57±0.46### 0.42±0.28 7.23±2.01⁎ # 3.21±0.85# 4.04±1.38⁎
18:1 n-9c 2.42±0.62 15.7±3.58 16.27±3.38 16.81±4.51 2.92±1.29 15.57±3.03 18.18±2.48 20.39±4.53
18:1 n-7 0.30±0.24 10.19±2.72 7.56±0.84 6.24±0.94 0.65±0.34 12.27±1.98 11.78±1.86⁎ 9.56±2.15
18:2 n-6c 0.00±0.00# 2.67±1.08 2.31±1.17 2.28±0.67 0.91±0.58 1.38±1.01 1.19±0.52 1.27±0.70
20:2 n-6 0.00±0.00 0.30±0.07 0.99±0.29# 0.68±0.07 0.05±0.04 0.08±0.07 0.51±0.48 0.68±0.18
20:3 n-6 0.00±0.00 0.22±0.04# 1.13±0.01### 0.78±0.09# 0.05±0.04 0.13±0.07 0.39±0.29 0.48±0.18
20:4 n-6 0.30±0.24 1.19±0.77 5.44±2.24 8.22±1.87 0.45±0.23 0.26±0.19 1.51±0.90 4.44±2.54
20:5 n-3 0.42±0.39 0.14±0.07 0.00±0.00### 1.15±0.07 0.52±0.39 0.05±0.04 0.10±0.10 0.7±0.39
22:4 n-6 0.00±0.00 0.00±0.00 0.00±0.00# 0.08±0.02 0.06±0.02 0.01±0.01 0.08±0.07 0.38±0.19
22:5 n-3 0.00±0.00 0.26±0.09# 1.79±0.23 4.24±0.62# 0.21±0.12 0.03±0.03⁎ # 0.39±0.21⁎ 1.60±0.38⁎
22:6 n-3 0.00±0.00 0.15±0.02### 1.43±0.13 3.54±0.22 0.14±0.09 0.04±0.04⁎ ### 0.26±0.07⁎⁎⁎ # 1.01±0.26⁎⁎
24:1 n-9 11.08±3.09 0.00±0.00 0.22±0.13 0.00±0.00 13.22±0.44# 0.03±0.02 0.14±0.12 0.00±0.00
Saturated/unsaturated 5.44±1.97 1.55±0.20# 1.38±0.06 0.73±0.07# 3.64±1.09⁎ 1.36±0.31# 1.40±0.11# 0.56±0.07⁎ #
n-3/n-6 1.41±0.00 0.13±0.01# 0.33±0.16 0.74±0.17 0.58±0.23 0.06±0.06# 0.21±0.11 0.46±0.13
Fatty acid contents were expressed in mol% and the values represent the mean±SE from three independent determinations.
*pb0.05, **pb0.01, ***pb0.005 myotubes vs. myoblasts.
#pb0.05, ##pb0.01, ###pb0.005 DRM vs. TM.
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(Table 1). It is noteworthy that the important increase of the CH/
GPL and SM/GPL ratios in DRM as compared to TM is in accordance
with the particular lipid composition of these domains, as commonly
reported [9]. As observed for TM, the ratio of sphingomyelin to
glycerophospholipids did not differ signiﬁcantly between myoblast
and myotube DRMs. The fatty acid compositions of sphingolipids
and glycerophospholipids from L6 myoblast and myotube DRMs
are shown in Table 2. As already observed for TM, the saturated to
unsaturated ratio was decreased in DRM from differentiated cells
compared to myoblasts. This decrease was essentially due to higher
amounts of 16:1 n-7, 18:1 n-9 and 18:1 n-7 and lower percentages
of saturated fatty acids in DRM frommyotubes. The highest difference
in fatty acid content between the two types of cells was observed in
the saturated to unsaturated ratio in PC and PE species (Table 2).
A relative decrease of long chain polyunsaturated fatty acids was
also noticed. In regard to these PUFAs, DRM from myotubes had
the lowest percentages of 20:4 n-6, 22:4 n-6, and 22:5 n-3. The
total ratio of n-3 to n-6 PUFAs was markedly lower in DRM isolatedfrom differentiated myotubes. These observations indicate that sig-
niﬁcant changes in DRM lipid composition occur during myogenic
differentiation.
3.2. PUFA treatments affected proliferation and myogenic differentiation
of L6 cells
Morphological and biochemical studies were performed to exam-
ine the effect of PUFAs on cell differentiation. Conﬂuent cultures of
L6 cells were incubated in differentiation medium in the presence of
vehicle (i.e. fatty acid-free BSA) or 20 μM fatty acids (in complex with
BSA) for 4 days. The morphology of each specimen was ﬁrst assessed
using phase microscopy. Upon visual inspection (Fig. 2A–E), the forma-
tion ofmyotubeswas found to be signiﬁcantly increased in the presence
of 20 μM AA or DHA, and to a lesser extent of 20 μM EPA compared
to the control cells. The cells were also examined for myogenin immu-
noﬂuorescence to assess differentiation. Myotubes presented a charac-
teristic organization with a large amount of myogenin-positive nuclei.
PUFA-treated cells formed larger myotubes, with a higher number of
AB
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Fig. 2. Effect of PUFAs on myotube formation and myogenin expression. L6 cells were
induced to differentiate in DM in the absence (control, A and F) or presence of
20 μM OA (B and G), AA (C and H), EPA (D and I), or DHA (E and J). Representative
phase-contrast photographs of L6 cells after 4 days of treatment (A-E) and representa-
tive images of the myogenin immunoﬂuorescence labelling (F–J). Nuclear myogenin
was revealed by using a monoclonal anti-myogenin antibody and an Alexaﬂuor
488-conjugated secondary antibody.
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Fig. 3. Effect of PUFAs on the myogenic index. L6 cells were induced to differentiate
in DM in the absence (control) or presence of 20 μM OA, AA, EPA or DHA for 4 days.
The total number of nuclei and the number of nuclei incorporated into myotubes
were counted. The myogenic index was deﬁned as the fraction of nuclei residing in
cells containing three or more nuclei. Data were expressed as the means±SE of ten
randomly chosen ﬁelds from triplicate samples. *pb0.05 versus control, **pb0.005 versus
control.
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Fig. 4. Effects of PUFAs on the expression of caveolin-3. Caveolin-3 expression was
measured by Western blot analysis of proteins extracted from L6 cells. At time 0 cells
were shifted to DM in the absence (control BSA) or in the presence of 20 μM fatty
acid and cultured for a further 48 or 72 h before solubilization and Western blotting
with anti-caveolin antibody. (A) Representative Western blots of caveolin-3. 10 μg
of proteins were loaded in each lane. (B) Quantitation of caveolin-3 expression in
Western blots by densitometric analysis. The values were normalized to tubulin levels.
Caveolin-3 amounts are expressed in arbitrary units. The graph shows the means±SE
of three different experiments. **pb0.005 versus control.
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OA-treated cells (Fig. 2F–J). This was conﬁrmed by the quantiﬁcation
of the myogenic index, i.e. the fraction of nuclei residing in cells
containing≥3 nuclei, as a measure of myoblast fusion. In control cells,
27.7% of the nuclei were present in the differentiated cells after 96 h
(Fig. 3). Both AA and DHA signiﬁcantly enhanced L6 differentiation
(Fig. 2H and J, Fig. 3) by increasing the myogenic index to 32.3%
for 20 μM AA and 41.6% for 20 μM DHA. In parallel experiments,
L6 myoblasts in proliferation medium were treated with the same
concentrations of PUFAs during the same period of time. We observed
a signiﬁcant positive effect of all the tested PUFAs on myoblast
proliferation, with the number of cells being increased by 20% in the
presence of 20 μM AA and 30% with DHA (data not shown). Thus,PUFA treatments interfered with both myoblast proliferation and
differentiation, as reﬂected by the increase in myotube formation.
To evaluate the ability of PUFAs to elicit the expression of muscle
differentiation markers, we analyzedmyosin and caveolin-3 contents,
both known to be speciﬁc late markers of differentiation. Immuno-
blotting analysis, performed over a 4-day period, revealed that EPA
and DHA greatly increased the expression of caveolin-3 (Fig. 4A).
EPA- or DHA-treated cells showed about a 2.5-times higher expression
of caveolin-3 with respect to control cells. Cells treated with 20 μMAA
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Fig. 6. Creatine kinase activity of L6 cells cultured in PUFA-supplemented differentia-
tion medium. The L6 cells were shifted to DM in the absence (control BSA) or in the
presence of 20 μM fatty acid and cultured for further 96 h before homogenization.
Calculated CK activity was normalized to total protein concentration as determined
by the Bradford assay.
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expression of myosin was also increased in the presence of PUFAs,
but to a lesser extent than caveolin-3 (Fig. 5).
We then assessed the activity of creatine kinase, which is general-
ly accepted as a biochemical indicator of muscle-speciﬁc late gene
expression during myogenesis. As expected, the activity of creatine
kinase strongly increased (3 to 4-fold) in the presence of control
differentiation medium, when compared with the baseline level of
undifferentiated cells. When L6 myoblasts were treated with either
the mono unsaturated fatty acid oleate or PUFAs, no signiﬁcant
difference was observed in the level of creatine kinase-speciﬁc
activity (Fig. 6).
3.3. PUFA treatments modiﬁed the fatty acid composition of myotube
membranes
Various studies have shown that PUFA treatments alter membrane
lipid composition, causing functional effects on cell signalling [17–19].
Hence, we investigated whether exogenous PUFAs were incorporated
into the L6 myotube membranes, leading to altered membrane lipid
composition. The fatty acid composition of the membrane lipids
of control myotubes, and myotubes differentiated in the presence
of 20 μM monounsaturated OA (18:1n-9), polyunsaturated AA (20:4
n-6) or DHA (22:6 n-3), was analyzed (Table 3). When L6 cells were
treated with OA or AA, the corresponding fatty acid and its elongation
product (20:1 n-9, 22:1 n-9 and to a lesser extent 24:1 n-9, and 22:4
n-6, respectively) were enriched not only in the GPL of the TM but
evenmore in isolated DRMwhen compared to control cells. The incor-
poration of the n-6 fatty acid AA greatly reduced the n-3 to n-6 ratio
in TM and DRM, although no increase in the amount of n-6 PUFA
was observed in sphingolipids. The incorporation of exogenous DHA
was associated with an increased amount of both the supplemented
fatty acid and EPA (20:5 n-3).0
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Fig. 5. Effects of PUFAs on the expression of myosin. Myosin expression was measured
byWestern blot analysis of the proteins extracted from the L6 cells. Cells were cultured
for 48 or 72 h in DM, in the absence (control BSA) or in the presence of 20 μM fatty
acid and the whole-cell protein extracts were analyzed by Western blotting with an
anti-myosin antibody. (A) Representative Western blots of myosin. 10 μg of proteins
were loaded in each lane. (B) Quantitation of myosin expression in Western blots by
densitometric analysis. The values were normalized to tubulin levels. Myosin amounts
are expressed in arbitrary units. The graph shows the means±SE of two different
experiments. *pb0.05 versus control.The increased amounts of these n-3 PUFAs led to a compensatory
decrease in n-6 fatty acids. It is noteworthy that the extent of AA or
DHA enrichment was slightly lower in DRM than in TM, with values
of 4- and 6-fold for AA, and 19- and 23-fold for DHA, respectively.
Furthermore, a signiﬁcant decrease in monounsaturated oleic acid
(18:1 n-9) was observed under these conditions. The observed
decrease in 18:1, induced by AA supplementation in PC and PE
classes, as well as in PI/PS classes, was less pronounced in the DRM
fractions (36, 66% and 33%, respectively) compared to TM (45, 75%
and 50%, respectively). This decrease in 18:1 was also less important
in DRM than in TM after DHA supplementation.
The ratio of saturated to unsaturated fatty acids was increased in
TM as well as in the DRM from PUFA-treated cells when compared
to control cells. Palmitic (16:0) and stearic (18:0) acid content
was signiﬁcantly increased in the TM and DRM lipids of AA- and
DHA-supplemented cells. This likely indicates the occurrence of a
mechanism compensating for the massive incorporation of PUFAs
to maintain a high saturated to unsaturated ratio, typical of DRM.
Cholesterol was about 5 times enriched in DRM compared to TM, but
there were no signiﬁcant differences in cholesterol content of DRM
following PUFA treatment (data not shown). In summary, PUFAs
were effectively incorporated in DRM and signiﬁcantly altered the
lipid environment of DRM, although to a lesser extent than with TM.
3.4. PUFA treatments modulated p70S6K1 but not Akt phosphorylation
Because PUFAs proved able to alter membrane composition and
enhance the proliferation and myogenic response of L6 cells, we
investigated their impact on the Akt/mTOR signalling pathway,
which plays a major role in the regulation of these functions [6,27].
Akt is activated by growth factors, in particular IGFs in muscle tissue,
through PI3 kinase activation that triggers its phosphorylation on cru-
cial residues. Akt is a major activator of the mTORC1 complex, which
in turn positively regulates protein synthesis and cell growth through
the phosphorylation and the resulting activation of several effectors,
in particular the kinase p70S6K1. The levels of phosphorylation of Akt
on serine 473 and p70S6K1 on threonine 389 were evaluated over
a 4-day period in differentiating L6 cells (Fig. 7 and 8 respectively).
We found that a signiﬁcant increase in Akt activation was induced at
the onset of differentiation both in control and PUFA-treated cells.
The increase in Akt phosphorylation was transient, peaking at 48 h
and subsiding thereafter. Treatments by the various PUFAs did not
affect the Akt activation pattern, regardless of what fatty acid had
been added, demonstrating that Akt activity is not modulated by
exogenous PUFAs.
Table 3
Fatty acid composition of TM and DRM lipids from control (BSA) and PUFA-treated L6 myotubes.
TM BSA OA AA DHA
Fatty acids PC PI/PS PE PC PI/PS PE PC PI/PS PE PC PI/PS PE
14:0 6.60±0.69 0.90±0.01 0.53±0.02 6.57±0.59 1.05±0.29 0.62±0.17 8.10±0.70 0.87±0.09 0.46±0.17⁎ 6.98±0.35 0.84±0.04 0.41±0.05
16:0 25.09±1.04 8.08±0.04 5.58±0.22 24.77±1.11 7.96±1.14 5.98±1.16 34.01±1.19⁎⁎ 8.54±0.28 5.95±0.41 29.86±0.59⁎ 8.91±0.08⁎⁎ 5.22±0.48
18:0 7.22±0.24 35.89±0.54 10.62±0.11 7.16±0.54 35.02±0.32⁎ 9.89±0.65 8.87±0.32⁎⁎ 40.57±0.80⁎⁎ 12.77±1.29⁎⁎⁎ 9.23±0.06⁎⁎ 41.32±2.35⁎ 11.10±0.73
20:0 0.12±0.03 0.30±0.06 0.32±0.07 0.07±0.03⁎⁎⁎ 0.18±0.06⁎⁎⁎ 0.18±0.10⁎ 0.103±0.02 0.25±0.06 0.15±0.08⁎ 0.07±0.01 0.21±0.02 0.10±0.02⁎
22:0 0.03±0.03 0.22±0.07 0.15±0.05 0.05±0.02 0.15±0.01 0.09±0.03⁎ 0.07±0.03 0.20±0.01 0.19±0.06 0.08±0.01 0.15±0.08 0.31±0.05
24:0 0.00±0.00 0.09±0.03 0.02±0.02 0.03±0.02 0.08±0.03 0.04±0.03 0.03±0.02 0.00±0.00⁎ 0.06±0.03⁎ 0.01±0.01 0.05±0.04 0.00±0.00
16:1 n-9 3.98±0.01 1.72±0.15 0.64±0.12 4.66±0.16⁎ 2.02±0.18⁎ 0.70±0.16 2.79±0.13⁎⁎⁎ 0.99±0.02⁎ 0.22±0.02⁎ 3.15±0.01⁎⁎⁎ 1.35±0.10⁎ 0.32±0.02⁎
16:1 n-7 13.58±1.13 5.85±0.36 7.02±0.54 9.65±0.22⁎ 3.84±0.39⁎ 3.67±0.30⁎ 6.30±0.30⁎⁎ 1.88±0.11⁎⁎⁎ 1.34±0.74⁎⁎ 8.154±0.41⁎ 2.67±0.18⁎⁎ 2.08±0.08⁎⁎⁎
18:1 n-9c 20.33±0.69 21.27±0.58 22.20±0.38 27.62±2.01⁎ 28.64±0.85⁎⁎⁎ 26.60±0.78⁎ 11.34±0.98⁎⁎⁎ 10.68±0.72⁎⁎⁎ 5.56±0.85⁎⁎⁎ 19.52±0.44 17.51±0.23⁎ 10.96±0.26⁎⁎⁎
18:1 n-7 15.68±0.16 14.03±1.03 12.08±0.63 12.05±0.16⁎⁎⁎ 10.65±0.45 8.88±0.77 8.37±0.06⁎⁎⁎ 6.94±0.22⁎⁎ 3.65±1.03⁎⁎ 10.41±0.34⁎⁎⁎ 9.33±0.55⁎ 4.25±0.34⁎⁎⁎
18:2 n-6c 0.68±0.01 0.48±0.02 0.73±0.02 0.75±0.13 0.55±0.04⁎ 0.72±0.03 0.46±0.08⁎ 0.30±0.12 0.19±0.06⁎⁎⁎ 1.23±0.04⁎⁎⁎ 0.49±0.10 0.49±0.02⁎⁎⁎
20:1 n-9 0.35±0.08 0.52±0.11 1.42±0.00 0.73±0.08 1.10±0.18 2.82±0.18⁎⁎ 0.18±0.06⁎ 0.16±0.04⁎ 0.27±0.03⁎⁎⁎ 0.27±0.02 0.31±0.02 0.28±0.02⁎⁎⁎
20:2 n-6 0.21±0.21 0.05±0.02 0.04±0.01 0.03±0.01 0.09±0.04 0.06±0.02 0.04±0.03 0.04±0.02 0.05±0.01 0.03±0.00 0.08±0.02 0.03±0.00
20:3 n-6 0.18±0.00 0.61±0.02 0.45±0.01 0.18±0.04 0.55±0.06 0.39±0.04 0.47±0.06⁎ 0.71±0.12 0.39±0.04⁎⁎ 0.29±0.01⁎⁎⁎ 0.68±0.11 0.28±0.01⁎⁎⁎
20:4 n-6 0.51±0.10 2.36±0.03 5.13±0.38 0.58±0.15 2.25±0.46 5.33±0.48 12.64±0.19 16.42±0.33⁎⁎⁎ 18.12±0.86⁎⁎⁎ 0.79±0.01⁎ 3.13±0.17⁎ 3.41±0.17⁎
20:5 n-3 0.04±0.04 0.06±0.06 0.67±0.01 0.05±0.05 0.06±0.04 0.63±0.10 0.05±0.05 0.01±0.01 0.11±0.06⁎⁎⁎ 1.11±0.04⁎⁎⁎ 1.16±0.12⁎⁎⁎ 2.98±0.00⁎⁎⁎
22:1 n-9 0.05±0.05 0.24±0.08 0.17±0.06 0.14±0.03 0.48±0.13 0.38±0.04 0.06±0.02 0.16±0.02 0.09±0.03 0.06±0.02 0.22±0.07 0.09±0.03
22:4 n-6 0.03±0.01 0.25±0.00 0.78±0.06 0.05±0.01 0.32±0.02⁎ 0.91±0.07⁎⁎⁎ 2.05±0.02⁎⁎⁎ 7.41±0.25⁎⁎⁎ 17.62±1.03⁎⁎⁎ 0.06±0.01 0.24±0.02 0.47±0.06⁎
22:5 n-3 0.14±0.01 0.74±0.02 2.15±0.07 0.14±0.05 0.73±0.16 2.16±0.24 0.28±0.03⁎ 0.88±0.04⁎ 2.07±0.62 0.32±0.02⁎⁎⁎ 0.95±0.11 1.754±0.03⁎⁎
22:6 n-3 0.16±0.03 0.50±0.00 1.51±0.09 0.16±0.07 0.48±0.09 1.50±0.324 0.24±0.03⁎ 0.43±0.05 1.17±0.21⁎ 3.81±0.27⁎⁎⁎ 7.24±0.76⁎⁎⁎ 25.36±0.22⁎⁎⁎
24:1 n-9 0.06±0.02 0.11±0.01 0.00±0.00 0.07±0.02 0.20±0.01 0.04±0.01⁎ 0.04±0.00 0.13±0.01 0.00±0.00 0.04±0.01 0.11±0.04 0.01±0.01
Saturated/unsaturated 0.70±0.02 0.93±0.02 0.31±0.01 0.68±0.07 0.86±0.04⁎ 0.31±0.03 1.13±0.07⁎⁎ 1.07±0.05⁎ 0.39±0.03⁎⁎ 0.94±0.02⁎⁎⁎ 1.13±0.09⁎ 0.32±0.02
n-3/n-6 0.21±0.01 0.35±0.01 0.61±0.04 0.22±0.07 0.34±0.04 0.58±0.03 0.04±0.01⁎⁎⁎ 0.05±0.00⁎⁎⁎ 0.09±0.02⁎⁎ 2.18±0.18⁎⁎⁎ 2.02±0.03⁎⁎⁎ 6.43±0.32⁎⁎⁎
DRM BSA OA AA DHA
Fatty acids PC PI/PS PE PC PI/PS PE PC PI/PS PE PC PI/PS PE
14:0 7.96±2.43 1.11±0.29 0.95±0.36 7.57±2.23 1.44±0.23 0.96±0.08 9.64±2.73 1.89±0.05 0.84±0.21 8.54±2.96 1.71±0.01 0.45±0.45
16:0 38.02±3.28 14.73±0.44 10.62±0.92 36.52±1.42⁎⁎ 12.20±0.52⁎⁎⁎ 9.61±0.27 47.70±0.83 16.46±0.70⁎ 11.92±0.34 41.245±0.90 15.93±0.08 10.42±0.18
18:0 7.86±0.59 38.86±2.22 13.66±0.23 7.69±1.23 37.15±3.28 13.23±0.90 8.03±0.89 36.97±1.93 17.20±0.39⁎⁎ 9.19±0.97⁎ 38.94±2.19 15.15±0.87
20:0 0.07±0.05 0.15±0.10 0.16±0.11 0.02±0.01⁎ 0.21±0.03 0.09±0.01 0.03±0.03 0.00±0.00 0.16±0.00 0.02±0.02 0.21±0.07 0.14±0.05
22:0 0.00±0.00 0.00±0.00 0.03±0.04 0.02±0.02 0.11±0.08 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.01±0.01 0.04±0.04 0.00±0.00
24:0 0.01±0.01 0.07±0.10 0.01±0.02 0.00±0.00 0.00±0.00 0.03±0.04 0.02±0.02 0.00±0.00 0.38±0.38 0.02±0.02 0.13±0.10 0.05±0.05
16:1 n-9 2.53±0.23 1.51±0.16 0.68±0.12 3.12±0.82 2.45±0.93 0.79±0.19 1.70±0.07⁎ 1.45±0.33 0.44±0.15 1.92±0.04⁎ 1.49±0.19 0.66±0.18
16:1 n-7 7.23±1.64 3.21±0.69 4.04±1.13 4.74±1.76⁎⁎ 2.05±0.49⁎ 2.18±1.16 3.82±0.20 2.30±0.52 1.08±0.13 5.40±0.33 2.27±0.14 2.34±0.15
18:1 n-9c 15.57±2.47 18.18±2.03 20.39±3.70 24.94±1.73⁎ 26.17±2.38⁎ 27.73±0.54 10.11±1.13⁎ 12.26±0.27⁎ 7.03±0.59⁎ 16.46±1.08 16.70±0.86 15.96±0.02
18:1 n-7 12.27±1.62 11.78±1.52 9.56±1.76 8.44±3.03⁎ 6.42±2.20⁎⁎⁎ 6.38±2.08 7.68±0.21⁎ 7.54±0.69 4.6±0.11⁎ 9.62±0.55 9.79±0.77 4.86±0.13⁎
18:2 n-6c 1.38±0.98 1.19±0.43 1.27±0.58 0.58±0.05 0.87±0.06 0.54±0.07 0.45±0.14 1.24±0.02 0.53±0.18 0.77±0.05 0.67±0.00 0.70±0.05
20:1 n-9 0.33±0.07 0.62±0.12 1.71±0.15 0.80±0.24 1.71±0.64 4.16±1.22 0.14±0.02 0.27±0.12 0.44±0.01⁎⁎⁎ 0.24±0.04 0.46±0.06 0.67±0.07⁎
20:2 n-6 0.08±0.07 0.51±0.48 0.68±0.18 0.11±0.16 0.00±0.00 3.57±1.74 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00
20:3 n-6 0.13±0.06 0.39±0.32 0.48±0.15 0.09±0.02 0.29±0.01 0.12±0.14 0.26±0.04 0.44±0.04 0.32±0.02 0.14±0.01 0.38±0.07 0.26±0.03
20:4 n-6 0.26±0.15 1.51±0.77 4.44±2.08 0.33±0.26 1.18±0.42 2.95±0.75 5.52±0.15⁎⁎⁎ 8.08±1.08⁎⁎ 15.85±0.44⁎ 0.27±0.00 1.59±0.30 2.823±0.21
20:5 n-3 0.05±0.04 0.10±0.08 0.70±0.32 0.03±0.01 0.07±0.02 0.26±0.04 0.05±0.01 0.00±0.00 0.14±0.00 0.28±0.04⁎ 0.47±0.08⁎ 1.76±0.03⁎
22:1 n-9 0.02±0.03 0.15±0.03 0.17±0.04 0.14±0.05 0.38±0.09 0.51±0.10⁎ 0.05±0.05 0.26±0.16 0.14±0.07 0.03±0.03 0.12±0.12 0.07±0.07
22:4 n-6 0.01±0.02 0.08±0.07 0.38±0.16 0.04±0.04 0.33±0.24 0.76±0.64 0.85±0.02⁎⁎⁎ 3.16±0.28⁎⁎ 14.66±0.72⁎⁎⁎ 0.03±0.01 0.19±0.05 0.40±0.03
22:5 n-3 0.03±0.04 0.39±0.17 1.60±0.31 0.04±0.03 0.34±0.12 0.96±0.16 0.12±0.01 0.56±0.22 1.77±0.07 0.11±0.00 0.48±0.09 1.22±0.02
22:6 n-3 0.04±0.03 0.26±0.06 1.01±0.22 0.04±0.01 0.16±0.01 0.49±0.10 0.04±0.04 0.27±0.05 0.98±0.10 1.15±0.12⁎⁎⁎ 3.28±0.32⁎⁎⁎ 17.52±0.28⁎⁎⁎
24:1 n-9 0.06±0.08 0.14±0.12 0.00±0.00 0.18±0.04 0.24±0.11 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.12±0.07 0.29±0.04 0.00±0.00
Saturated/unsaturated 1.35±0.25 1.37±0.09 0.54±0.06 1.19±0.12 1.20±0.14 0.47±0.02 2.12±0.11⁎ 1.46±0.18 0.64±0.00 1.63±0.10 1.49±0.10 0.54±0.04
n-3/n-6 0.06±0.06 0.21±0.09 0.46±0.10 0.10±0.05 0.21±0.05 0.21±0.02 0.03±0.00 0.06±0.01⁎ 0.09±0.01⁎ 1.27±0.09⁎⁎⁎ 1.49±0.05⁎⁎⁎ 4.89±0.44⁎⁎⁎
Fatty acid contents were expressed in mol% and the values represent the mean±SE from three independent determinations.
* Asterisks indicate signiﬁcant differences to BSA *pb0.05 **pb0.01 ***pb0.005. 609
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Fig. 7. Akt is transiently up-regulated during L6 cell differentiation but not affected by
exogenous PUFAs. Protein extracts were prepared from L6 cells after 14, 24, 48 or
72 h of differentiation in DM in the absence (control BSA) or presence of the indicated
fatty acid. After SDS-PAGE and transfer to PVDF membranes, immunoblotting was
performed with a phospho-Serine 473-Akt speciﬁc antibody. (A) Representative
Western blots of Akt. Note the presence of a peak of Akt phosphorylation after 48 h of
differentiation whatever the treatment. Each lane contained equal amounts of total
proteins. (B) The blots were quantitated by densitometric analysis, and normalized by
tubulin amounts. Data represent the means±SE of two different experiments.
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Fig. 8. p70S6K1 phosphorylation is increased during L6 cell differentiation and
enhanced by exogenous PUFAs. Protein extracts were prepared from L6 cells after 14,
24, 48 or 72 h of differentiation in DM in the absence (control BSA) or presence of
the indicated fatty acid. After SDS-PAGE and transfer to PVDF membranes, immuno-
blotting was performed with a phospho-Threonine 398-S6K1 speciﬁc antibody.
(A) Representative Western blots of p70S6K. Note the clear increase in p70S6K1
phosphorylation after 48 h of differentiation in the presence of n-3 or n-6 added
PUFA. Each lane contained equal amounts of total proteins. (B) The blots were quanti-
tated by densitometric analysis, and normalized to tubulin amounts. Data represented
the means±SE of two different experiments. *pb0.05 versus control.
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p70S6K1, as evaluated by T389-phosphorylation (Fig. 8). The differ-
entiation process was also accompanied by an activation of p70S6K1
in the control cells, but this started later than for Akt. Indeed, the
increase in phosphorylation was only detectable at 48 h, and much
more marked at 72 h. OA addition induced no signiﬁcant change in
this pattern, whereas the addition of n-6 and n-3 fatty acids caused
an earlier and stronger activation of p70S6K1, starting at 14 h for
AA and EPA and 24 h for DHA. At 48 h, the levels of phosphorylation
in the presence of PUFAs were 1.5–2 times that of the control cells. A
similar enhancement of the phosphorylation of the p85S6K1 isoform
during treatment by PUFAs was also observed (data not shown).
4. Discussion
During the differentiation process myoblast fusion, which gives
rise to multinucleated myotubes, involves the association of two
distinct membranes to form a single, continuous one. Although lipid
microdomain organization has been reported to be essential for nor-
mal myogenic differentiation, little is known about the redistribution
of membrane lipids as well as the recruitment of new lipids that are
speciﬁcally associated with myogenic differentiation. As a ﬁrst issue
in this paper we investigated how this myogenic differentiation
altered the membrane and DRM lipid composition, and secondly we
considered how modifying membrane lipid composition inﬂuenced
the myogenic process.
The presence of detergent-resistant fractions in various cell types
has already been demonstrated using different techniques [28–30].
Cold detergent insolubility has been adopted as the standard tech-
nique for isolating lipid domains, even though a still unsolved point
is to what extent the DRM fractions retain the characteristics of the
domains originally present in the membranes. For instance, changes
in the protein/detergent ratio have been shown to affect the compo-
sition of isolated fractions [31]. For this reason, the isolation of
DRM from L6 cells at various differentiation stages was carried out
keeping these conditions constant. It is noteworthy that we could
purify DRM from both L6 myoblasts and myotubes, regardless of the
presence or not of caveolin-3. Although it is known that caveolin-1
and caveolin-3 are capable of driving caveolae formation, our results
demonstrate that puriﬁcation of DRM could be achieved, using the
same detergent extraction protocol, from L6 myoblasts that only
express caveolin-1 or caveolin-2, and from L6 myotubes that express
the three isoforms.
The ﬁrst observed alterations associated with differentiation are
changes in the cholesterol to phospholipid ratio and in the saturated
to unsaturated fatty acid ratio, factors which both may contribute to
changes in membrane ﬂuidity [32,33]. We observed that the CH/GPL
ratio, as well as the saturated/unsaturated ratio, decreases signiﬁ-
cantly with differentiation, suggesting that membrane ﬂuidity is
necessary for membrane fusion, and might increase during this cellular
process. Although the same global effect has been reported for C2 cells
or the clonal line BC3H-1 [15,34], the presented analyses of total PL
fatty acid composition are not as informative as the fatty acid composi-
tion of individual PL species. Striking differences in the fatty acid
composition of myoblast and myotube membranes were observed in
the PC, PI/PS and PE fractions. Our results show that in addition to a
decrease in 16:0, 18:0, and polyunsaturated fatty acids in myotube
membranes, a notable increase in n-7 and n-9 monounsaturated
(16:1 n-7, 18:1 n-7 and 18:1 n-9) fatty acids was observed for the
analyzed glycerophospholipids. Myogenic differentiation induces
changes in several metabolic pathways, including fatty acid elongation
and desaturation. Thus, the observed increase in the content of some
unsaturated fatty acids (such as oleic acid) could be due to the activa-
tion of a Δ9 desaturase.
It has been suggested that the fatty acid composition of the
cultured cells mirrors the one of the medium in which they were
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switch from a serum-rich medium to a less rich medium after the
cells have reached conﬂuence. Unlike what is used in many other
studies, we induced differentiation by using the same fetal bovine
serum (FBS), although at a lesser concentration in the differentiation
medium. We performed the analysis of the FBS that we used, and
observed that the saturated and monounsaturated FA were the
most abundant (25% of 16:0, 13% of 18:0 and 19% of 18:1n-9), while
PUFAs were minor components (with 3.8% for AA and 2.2% for
DHA). The lipid composition of the serum was clearly different from
that of TM or DRM from both myoblasts and myotubes, and it thus
seems likely that the changes that accompany differentiation were
due to the differentiation itself rather than to the lower serum con-
tent in the differentiation medium.
This medium also contained AVP, which was reported to stimulate
phospholipases, such as phospholipase A2 (PLA2), phospholipase C
(PLC) as well as phospholipase D (PLD). However, the concentrations
of AVP required to induce myogenesis are only compatible with the
activation of phospholipase D, whereas 100-fold higher AVP doses
are required to trigger the stimulation of phospholipase C [35,36]. It
is noteworthy that PLD1 expression is down-regulated as soon as
the L6 cells begin to differentiate [37]. This decrease was observed
in both cells differentiated by culture in low-serum medium and
those differentiated in the presence of AVP, showing that the
down-regulation of PLD was linked to the differentiation itself,
regardless of the method for its induction. The effect of AVP on PLD
activity is thus expected to have little consequence on myotube
lipid composition. On the other hand, the activation of phospholipase
A2 by AVP during the differentiation process could lead to a lower
percentage of arachidonate in myotube compared to myoblast mem-
branes, due to a release of arachidonate which could ultimately
be metabolized into prostaglandins [38]. Future research should de-
termine the impact of this metabolism on the lipid composition of
myotube membranes.
Whereas the lipid and fatty acid composition of total membranes
was signiﬁcantly modiﬁed during the myogenic process, the DRMs
were invariably enriched in cholesterol, sphingomyelin and saturated
fatty acids. Myotube DRM contained a lower proportion of cholesterol
than undifferentiated myoblasts. However, the decrease in the CH/
GPL ratio was not as important as the one observed for total mem-
branes. Furthermore, the relative enrichment in cholesterol was
very similar for both preparations of DRM when compared to the
heavy fractions (data not shown). Similarly to what was observed in
total membranes, but to a lower extent, the analysis of the DRM
fatty acyl composition of speciﬁc PL species shows a lower amount
of 16:0 and 18:0 in myotubes compared to myoblasts, and also a
decrease in polyunsaturated fatty acid percentages (20:5 n-3 and
22:6 n-3). These changes correlate with a decrease in cholesterol
during differentiation, and could be related to the more extended
structure of saturated acyl chains compared to unsaturated ones,
and their ability to better pack into each other and with cholesterol
[39]. The lower degree of fatty acid saturation and cholesterol content
associated with differentiation would thus allow a looser packing of
the lipid bilayer, and probably a lower rigidity of the membrane in
myotubes as compared with myoblasts.
In addition, our results showed that as myoblast differentiation
leads to a decrease in long chain PUFAs, this variation is accompanied
by a modiﬁcation of the n-3 to n-6 ratio in myotube membrane
lipids, essentially in the PC and PE species. PUFA acyl chains are
extremely ﬂexible and can rapidly change conformational states.
However, the acyl chain ﬂexibility differs between n-3 and n-6
fatty acids and the number of double bonds signiﬁcantly alters
membrane ﬂuidity [40,41]. In our study, the observed variation in
the n-3 and n-6 fatty acyl composition of L6 membranes during dif-
ferentiation could be related to modiﬁcations in the physical proper-
ties of the lipid membrane. Besides, it is likely that the changes inPUFA composition within the membrane phospholipids inﬂuence
the distribution and activity of proteins, and thereby affect the
differentiation mechanism. It was recently shown that dynamic
clustering and dispersion of lipid rafts play a key role in the changes
in plasma membrane composition that occur prior to membrane
fusion in myogenic cells, demonstrating that lipid rafts control cell
fusion in a particular mode [42]. Our study provides further insights
into the lipid modiﬁcations that take place in lipid rafts during myo-
genic differentiation.
In vitro observations suggest that lipid rafts are sensitive to bilayer
remodelling induced by manipulating the type of PUFAs provided to
the cells in culture [17–19,43]. In the present study, we investigated
the effect of PUFA supplementation on the L6 membrane fatty acid
composition and the consequences for cell differentiation. Previous
in vitro studies have shown stimulatory effects of various fatty acids
(including linoleic acid, isomers of conjugated linolenic acid, n-3
and n-6 PUFAs) on the differentiation of rat L6, or mouse C2C12
skeletal muscle cells into myotubes [20,21]. To our knowledge, our
study is the ﬁrst to compare the effects of n-3 and n-6 PUFAs on
the differentiation of skeletal muscle cells, including in parallel the
analysis of changes in lipid composition occurring in both DRM and
total membranes.
The presented results showed that PUFAs promote themorpholog-
ical changes linked to myogenic differentiation, as reﬂected by the in-
creased myogenic index. Differentiation of PUFA-supplemented cells
resulted in an increased expression of muscle-speciﬁc proteins, such
as caveolin and myosin, compared to control cells. Surprisingly,
creatine kinase activitywas notmodiﬁed after PUFA supplementation,
although it is considered a reliable marker for the degree of differenti-
ation in the C2C12mousemuscle cell line and primary skeletal muscle
cells [44,45].
Evaluation of the cell membrane fatty acid proﬁle revealed a
signiﬁcant enrichment of either AA or DHA into the membranes of
L6 cells treated with the corresponding fatty acid. This is consistent
with other reports demonstrating the incorporation of n-3 and n-6
PUFA into the membrane of different cell types both in vitro
[43,46,47] and in vivo [10,17,48] as well as the incorporation into
the whole skeletal muscle [11]. The addition of exogenous DHA
(22:6 n-3) was associated with an increased incorporation of the
supplemented fatty acid, and of EPA (20:5 n-3), probably originating
from the retroconversion of DHA to EPA by L6 cells [46,49–51].
Since extensive membrane reorganization occurs during myoblastic
differentiation (as evidenced by a decrease in PUFAs content), it
was rather surprising that PUFA incorporation in total membrane
enhanced myogenic differentiation. Furthermore, we also observed a
signiﬁcant enrichment of AA and DHA into DRM of PUFA-treated L6
myotubes with a concomitant decrease of mono-unsaturated fatty
acids. Therefore, the notion that DHA is excluded from DRM because
of its structural incompatibility with cholesterol was not veriﬁed in
this case. In what can be viewed as a compensatory mechanism
maintaining the DRM properties, fatty acid composition of L6 DRM
also evidenced moderately increased levels of saturated fatty acids,
compatible with the high packing of liquid-ordered raft domains
[52]. PUFA supplementation not only increased the levels of the
corresponding n-3 or n-6 PUFA, but also decreased n-9 fatty acids in
both total membrane and DRM preparations. This could be related to
a reduced expression ofΔ9 desaturase induced by PUFAs, as suggested
by previous studies showing that long-chain PUFAs reduce the
expression of this enzyme, with as a consequence lowered levels
of monounsaturated and increased levels of saturated fatty acids
[53,54].
The modulation of myogenic differentiation by PUFA supple-
mentation can probably not be solely explained by modulation of
metabolic pathways such as elongation/desaturation. It seems likely
that the alteration of the fatty acyl composition of membrane
lipids could directly affect the displacement of proteins from DRM
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inﬂuence the action of signalling complexes by acting as precursors
for eicosanoids synthesis.
The role of Akt, a downstream effector of PI3 kinase, and p70S6K1
in cell growth and survival has been extensively studied [55]. Activa-
tion of the Akt-mTOR-p70S6K1 pathway mediates both differentia-
tion in myoblasts and hypertrophy in myotubes [6]. Skeletal muscle
differentiation clearly requires the coordination of multiple signalling
pathways that regulate speciﬁc gene expression. In particular, a
promyogenic role has been assigned to mitogen-activated protein
kinase (MAPK) pathways, and to the PI3 kinase-Akt pathway
[56,57]. Membrane translocation is a prerequisite for the full activa-
tion of Akt by enabling successive phosphorylations [58] by kinases
such as PDK. It was reported that the translocation of Akt to the plas-
ma membrane is neither efﬁcient nor stable upon interaction with
PIP3 only, but also requires the interaction with acidic phospholipids
in the membrane, but not at the PIP3 binding pocket [59]. Activation
and phosphorylation of Akt might thus be modulated by modiﬁca-
tions of both the phospholipid and the fatty acid composition of
the membrane. Furthermore, there is evidence in the literature that
certain fatty acids can induce the activation of MAPK signalling
[60,61]. In the present study, we found that exogenous PUFAs signif-
icantly increased p70S6K1 phosphorylation during differentiation,
independently of changes in the phosphorylation of Akt. Akt phos-
phorylation occurred earlier than p70S6K1 phosphorylation during
the differentiation process, and was not modiﬁed by the addition of
fatty acids. These ﬁndings suggest that p70S6K1 might mediate the
stimulatory action of n-3 or n-6 PUFAs on the differentiation process,
possibly via its effects on protein translation and the expression of
myogenic factors. The lack of signiﬁcant effects of these PUFAs on
Akt activation shows that the fatty acids altered neither the activity
of Akt at the plasma membrane nor its translocation to the correct
site. In addition, it suggests that mTORC1 and its effector p70S6K1
could be activated by fatty acids via a pathway other than the Akt
pathway, possibly a MAPK pathway.
In conclusion, our results showed that n-3 as well as n-6 PUFAs
presented a marked activating effect on the myogenic differentiation
of L6 cells, based on an increased myogenic index and the expression
of caveolin and myosin. In parallel, these PUFAs profoundly altered
membrane and DRM lipid composition. These results support the
hypothesis that fatty acyl composition of total membrane and DRM
inﬂuence signalling complexes involved in myogenic differentiation.
The mechanism by which PUFAs activate the mTORC1/p70S6K1 sig-
nalling pathway and whether this signal is the cause of enhanced
myogenic response remain to be investigated.Acknowledgements
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